Jessica Chubak to Drug Administration Schedule
This is a "connection" page, showing publications Jessica Chubak has written about Drug Administration Schedule.
Connection Strength
0.099
-
Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control. 2007 Nov; 18(9):1001-7.
Score: 0.073
-
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57.
Score: 0.026